These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 5652122)

  • 1. Utilization of hydrophilic gums for the control of drug substance release from tablet formulations. II. Influence of tablet hardness and density on dissolution behavior.
    Huber HE; Christenson GL
    J Pharm Sci; 1968 Jan; 57(1):164-7. PubMed ID: 5652122
    [No Abstract]   [Full Text] [Related]  

  • 2. Utilization of hydrophilic gums for the control of drug release from tablet formulations. I. Disintegration and dissolution behavior.
    Huber HE; Dale LB; Christenson GL
    J Pharm Sci; 1966 Sep; 55(9):974-6. PubMed ID: 4380607
    [No Abstract]   [Full Text] [Related]  

  • 3. Does the performance of wet granulation and tablet hardness affect the drug dissolution profile of carvedilol in matrix tablets?
    Košir D; Ojsteršek T; Vrečer F
    Drug Dev Ind Pharm; 2018 Sep; 44(9):1543-1550. PubMed ID: 29848075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of hydrophilic natural gums in formulation of oral-controlled release matrix tablets of propranolol hydrochloride.
    Rajesh KS; Venkataraju MP; Gowda DV
    Pak J Pharm Sci; 2009 Apr; 22(2):211-9. PubMed ID: 19339235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative studies of binding potential of Prunus armeniaca and Prunus domestica gums in tablets formulations.
    Rahim H; Khan MA; Sadiq A; Khan S; Chishti KA; Rahman IU
    Pak J Pharm Sci; 2015 May; 28(3):909-14. PubMed ID: 26004724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of drug release kinetics of shellac-based matrix tablets by in-situ polymerization through annealing process.
    Limmatvapirat S; Limmatvapirat C; Puttipipatkhachorn S; Nunthanid J; Luangtana-anan M; Sriamornsak P
    Eur J Pharm Biopharm; 2008 Aug; 69(3):1004-13. PubMed ID: 18362064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rosin and rosin derivatives as hydrophobic matrix materials for controlled release of drugs.
    Pathak YV; Dorle AK
    Drug Des Deliv; 1990 Sep; 6(3):223-7. PubMed ID: 2076181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro release of ketoprofen from hydrophilic matrix tablets containing cellulose polymer mixtures.
    Vueba ML; Batista de Carvalho LA; Veiga F; Sousa JJ; Pina ME
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1651-62. PubMed ID: 23094867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of oleo-gum resin as directly compressible tablet excipient and release retardant.
    Kumar P; Singh I
    Acta Pol Pharm; 2010; 67(3):307-13. PubMed ID: 20524434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-Layered Matrix of Shellac Wax-Lutrol in Controlled Dual Drug Release.
    Phaechamud T; Choncheewa CE
    AAPS PharmSciTech; 2016 Dec; 17(6):1326-1335. PubMed ID: 26694059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation of bi-layer matrix tablets of tramadol hydrochloride: Comparison of rate retarding ability of the incorporated hydrophilic polymers.
    Arif H; Al-Masum A; Sharmin F; Reza S; Sm Islam SA
    Pak J Pharm Sci; 2015 May; 28(3):855-61. PubMed ID: 26004717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastro-resistant characteristics of GRAS-grade enteric coatings for pharmaceutical and nutraceutical products.
    Czarnocka JK; Alhnan MA
    Int J Pharm; 2015; 486(1-2):167-74. PubMed ID: 25796126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of superdisintegrants on efavirenz release from tablet formulations.
    Rajesh YV; Balasubramaniam J; Bindu K; Sridevi R; Swetha M; Rao VU
    Acta Pharm; 2010 Jun; 60(2):185-95. PubMed ID: 21134855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and characterization of pH-independent sustained release tablet containing solid dispersion granules of a poorly water-soluble drug.
    Tran HT; Park JB; Hong KH; Choi HG; Han HK; Lee J; Oh KT; Lee BJ
    Int J Pharm; 2011 Aug; 415(1-2):83-8. PubMed ID: 21641985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation development of carvedilol compression coated tablet.
    Shah R; Patel S; Patel H; Pandey S; Shah S; Shah D
    Pharm Dev Technol; 2013; 18(4):906-15. PubMed ID: 21797662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Studies on preparation of sustained-release Shuxiong formulation, a traditional Chinese medicine compound recipe, using time-controlled release techniques].
    Song HT; Zhang Q; Jiang P; Guo T; Chen DW; He ZG
    Zhongguo Zhong Yao Za Zhi; 2006 Sep; 31(17):1413-7. PubMed ID: 17087078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and evaluation of once-daily sustained-release coated tablets of tolterodine-L-tartrate.
    Pradhan R; Kim YI; Chang SW; Kim JO
    Int J Pharm; 2014 Jan; 460(1-2):205-11. PubMed ID: 24184032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydroxypropyl methylcellulose based cephalexin extended release tablets: influence of tablet formulation, hardness and storage on in vitro release kinetics.
    Saravanan M; Sri Nataraj K; Ganesh KS
    Chem Pharm Bull (Tokyo); 2003 Aug; 51(8):978-83. PubMed ID: 12913240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Native and microwave-modified Terminalia mantaly gums as sustained-release and bioadhesive excipients in naproxen matrix tablet formulations.
    Odeniyi MA; Oyedokun BM; Bamiro OA
    Polim Med; 2017; 47(1):35-42. PubMed ID: 29160627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ["Non-solvent shock agglomeration"--technology of a new alternative method for sustained release of ibuprofen. 5. Production and evaluation of retard formulations].
    Möller T; Korsatko W
    Pharmazie; 2000 Feb; 55(2):114-9. PubMed ID: 10723769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.